title: Psoriasin (S100A7) and calgranulin-B (S100A9) induction is dependent on reactive oxygen species and is downregulated by Bcl-2 and antioxidants.
abstract: S-100 proteins are calcium-binding proteins with important growth regulatory functions. Of these proteins, psoriasin and calgranulin-B have been shown to be highly upregulated in ductal carcinoma in situ (DCIS) of the breast and in psoriasis. The purpose of this study was to further elucidate the functional relevance of the overexpression of these two S-100 proteins in psoriasis and DCIS. We report the induction of both proteins by reactive oxygen species, phorbol ester TPA, and the induction of psoriasin in response to the PI3K inhibitor wortmannin. We also demonstrate that Bcl-2 overexpression represses the induction of psoriasin and calgranulin-B under these different conditions. The same effect was obtained with the antioxidant NAC, which indicates that the suppression of psoriasin and calgranulin-B induction is mediated by the antioxidant function of Bcl-2. Furthermore, we demonstrate that overexpression of a dominant negative IKKbeta also inhibits the induction of psoriasin suggesting that the NFkappaB pathway is involved in the induction of this protein. Also, we found NFkappaB responsive DNA elements in the upstream promoter region of psoriasin. MCF10A cells with a stable retroviral overexpression of psoriasin were significantly more resistant to H2O2-induced cell death than control cells further supporting the hypothesis that these S-100 proteins may play a role in oxidative stress response.
authors.affiliation: Department of Clinical Genetics, Sahlgrenska University Hospital, Göteborg, Sweden.
authors.forename: Hanna
authors.initials: H
authors.lastname: Carlsson
authors.forename: Maria
authors.initials: M
authors.lastname: Yhr
authors.forename: Stina
authors.initials: S
authors.lastname: Petersson
authors.forename: Nicole
authors.initials: N
authors.lastname: Collins
authors.forename: Kornelia
authors.initials: K
authors.lastname: Polyak
authors.forename: Charlotta
authors.initials: C
authors.lastname: Enerbäck
mesh_terms: D000111:Acetylcysteine / Q000494:pharmacology; D000975:Antioxidants / Q000494:pharmacology*; D002135:Calcium-Binding Proteins / Q000096:biosynthesis* / Q000235:genetics; D040502:Calgranulin B / Q000096:biosynthesis* / Q000235:genetics; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D015536:Down-Regulation; D004847:Epithelial Cells / Q000187:drug effects; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics / Q000378:metabolism*; D017382:Reactive Oxygen Species / Q000378:metabolism*; D000075023:S100 Calcium Binding Protein A7; D009418:S100 Proteins; D014407:Tumor Cells, Cultured
chemical_list: D000975:Antioxidants; D002135:Calcium-Binding Proteins; D040502:Calgranulin B; D019253:Proto-Oncogene Proteins c-bcl-2; D017382:Reactive Oxygen Species; D000075023:S100 Calcium Binding Protein A7; D009418:S100 Proteins; C089242:S100A7 protein, human; D000111:Acetylcysteine